MOTS-c is a 16-amino-acid peptide encoded within the mitochondrial genome, discovered in 2015 and classified as a "mitochondrial-derived peptide." It has become a focus of metabolic and exercise-physiology research due…
🔬 Studied for: Metabolic Research
💊 Also studied for: Exercise-Physiology Research
🧪 Not FDA-approved — sold strictly for laboratory research
📈 No standardized human dosage established in published literature
MOTS-c is a 16-amino-acid peptide encoded within the mitochondrial genome, discovered in 2015 and classified as a "mitochondrial-derived peptide." It has become a focus of metabolic and exercise-physiology research due to its apparent role in cellular energy regulation.
MOTS-c is studied for its ability to translocate to the nucleus under metabolic stress and regulate gene expression via AMPK activation, a pathway central to cellular energy sensing and glucose metabolism in preclinical models.
These are effects MOTS-C has been studied for in available preclinical and early research — not claims about guaranteed outcomes.
MOTS-c has been investigated in animal studies for its effects on insulin sensitivity and glucose metabolism, largely through its interaction with the AMPK signaling pathway.
Because circulating MOTS-c levels rise with exercise in some studies, it has been described as an "exercise mimetic" candidate and is studied for its potential role in mitochondrial adaptation to physical activity.
Doses used in the limited existing animal research vary by study design and are not established as a human protocol. No FDA-approved human dosage exists for MOTS-c.
Compound X does not provide dosing recommendations. MOTS-C is sold for laboratory research use only and is not intended for human consumption.
MOTS-c is not FDA-approved and has not completed large-scale human trials. Comprehensive human safety data does not yet exist; reported concerns in early research are limited given how recently the peptide was characterized.
No. MOTS-C is not FDA-approved for any indication and is sold strictly as a research chemical, not a medication or dietary supplement.
Metabolic Research — MOTS-c has been investigated in animal studies for its effects on insulin sensitivity and glucose metabolism, largely through its interaction with the AMPK signaling pathway.
In the US, UK, Canada and Australia, MOTS-C is generally sold labeled "for research use only, not for human consumption." It is not approved as a dietary supplement or medication in any of these countries.
MOTS-c research is indexed on PubMed under search terms such as "MOTS-c mitochondrial derived peptide" and "MOTS-c AMPK metabolism."
Compare current prices, purity testing claims and coupon codes across every vendor Compound X tracks.
New guides, vendor comparisons and compound breakdowns every week.